Clinical Trials Browser

Phase 2 × Salivary Cancer × enzalutamide × Clear all

NCT02749903 2026-02-11

Enzalutamide for Patients With Androgen Receptor Positive Salivary Cancers

Phase 2 Active not recruiting

46 enrolled 11 charts

Salivary Cancer